NAUTILUS BIOTECHNOLOGY, INC. CHANGE IN CONTROL AND SEVERANCE AGREEMENTChange in Control and Severance Agreement • May 3rd, 2022 • Nautilus Biotechnology, Inc. • Laboratory analytical instruments • Washington
This Change in Control and Severance Agreement (the “Agreement”) is made by and between Nautilus Biotechnology Inc., a Delaware corporation (the “Company”), and Gwen Weld (“Executive”), effective as of the date this Agreement is executed by both the Company and Executive (the “Effective Date”).
March 28, 2022 Gwen Weld Via email Re: Offer of Employment Dear Gwen:Offer of Employment • May 3rd, 2022 • Nautilus Biotechnology, Inc. • Laboratory analytical instruments
